OTCMKTS:CEOS Psykey (CEOS) Stock Price, News & Analysis $0.0081 +0.00 (+1.25%) As of 02/21/2025 03:42 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartHeadlinesShort Interest About Psykey Stock (OTCMKTS:CEOS) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Psykey alerts:Sign Up Key Stats Today's Range$0.0075▼$0.008150-Day Range$0.01▼$0.0452-Week Range$0.01▼$0.04Volume160,240 shsAverage Volume1.18 million shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewPsykey, Inc. engages in the research, development, and commercialization of entheogenic, adaptogenic, and nootropic ingredients and formulations for its functional product lines to improve and optimize life. The company also engages in the development of technologies for the composition, bioavailability, and targeted delivery of entheogen-based therapeutics for the psychedelic market. Its retail products include functional mushroom coffees and teas, oral supplements, and single serve drink mixes. The company was formerly known as CeCors, Inc. and changed its name to Psykey, Inc. in August 2021. Psykey, Inc. was founded in 2002 and is based in Toronto, Canada.Read More… Receive CEOS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Psykey and its competitors with MarketBeat's FREE daily newsletter. Email Address CEOS Stock News HeadlinesCeCors, Inc.: CEOS Engages National Law Firm as Outside Counsel, Prepares for Further GrowthJanuary 7, 2025 | finanznachrichten.deCEOS Engages National Law Firm as Outside Counsel, Prepares for Further GrowthJanuary 7, 2025 | finance.yahoo.comShocking Elon Move: Bigger than DOGE?After saving free speech with his acquisition of Twitter… And after blowing everyone’s minds with his recent DOGE moves… What Elon Musk is about to do next could not only shock the world… But also put an extra $30,000 a year in your pocket.February 22, 2025 | Brownstone Research (Ad)CeCors, Inc.: CeCors Announces Leadership Transition - Michael Maher, Distinguished Veteran and Leader, Named Interim CEOJanuary 1, 2025 | finanznachrichten.deAmerica’s CEOs don’t have the stomach for Trump’s promised revenge tourOctober 31, 2024 | cnn.comFortune 500 CEOs Have Made Their Choice Between Trump and Biden, Reveals Top Business School Prof.October 22, 2024 | msn.comPsykey, Inc. (CEOS) Stock Price, News, Quote & History - Yahoo FinanceOctober 19, 2024 | finance.yahoo.comMeet the Silicon Valley billionaires, corporate CEOS, and founders backing Kamala HarrisOctober 10, 2024 | businessinsider.comSee More Headlines CEOS Stock Analysis - Frequently Asked Questions How have CEOS shares performed this year? Psykey's stock was trading at $0.0390 at the beginning of the year. Since then, CEOS stock has decreased by 79.2% and is now trading at $0.0081. View the best growth stocks for 2025 here. How do I buy shares of Psykey? Shares of CEOS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Psykey own? Based on aggregate information from My MarketBeat watchlists, some other companies that Psykey investors own include Fernhill (FERN), Iconic Minerals (ICM), Puget Technologies (PUGE), Tonix Pharmaceuticals (TNXP), Amazonas Florestal (AZFL), Ayr Strategies (AYRSF) and Anavex Life Sciences (AVXL). Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Medical Instruments & Supplies Sub-IndustryWholesale Current SymbolOTCMKTS:CEOS CUSIPN/A CIKN/A Webwww.cecorsinc.com Phone(877) 348-1155FaxN/AEmployees6Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Investing Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free Report This page (OTCMKTS:CEOS) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredElon Social Security shock?“A Maniacal Sense of Urgency” We could be just days away from Elon Musk launching his next big venture. One...Altimetry | SponsoredMajor AI announcement for 2025BIG NEWS: “Market Wizard” Larry Benedict Releases a Whole New Way to Trade AI StocksBrownstone Research | SponsoredCritical ‘Buy Now’ Alert on My Favorite Stock!My absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | SponsoredA strange twist 500 miles from WashingtonEnergy is life. And this year, it could also make national heroes out of President Trump and VP Vance. ...Porter & Company | SponsoredThree new patents reveal Elon and Trump’s secret “Project America”Right now for a limited time… You can get Tim Bohen’s top 5 Trump stocks for 2025… For only ONE DOLLAR!...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Psykey, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Psykey With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.